{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,8]],"date-time":"2024-09-08T16:11:21Z","timestamp":1725811881139},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[1984,1,1]],"date-time":"1984-01-01T00:00:00Z","timestamp":441763200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[1984]]},"DOI":"10.1007\/bf00541935","type":"journal-article","created":{"date-parts":[[2004,11,18]],"date-time":"2004-11-18T18:01:42Z","timestamp":1100800902000},"page":"741-744","source":"Crossref","is-referenced-by-count":11,"title":["Fenofibrate therapy of hypertriglyceridaemias. Differential effects on LDL cholesterol level in Type IV and in Type IIb primary hyperlipoproteinaemia"],"prefix":"10.1007","volume":"26","author":[{"given":"D.","family":"Sommariva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Bonfiglioli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Pogliaghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Ottomano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Fasoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","first-page":"3747","volume":"9","author":"J Rouffy","year":"1980","unstructured":"Rouffy J, Sauvanet JP, Chann B, Bakir R, Goy-Leper J, Saya C, Pinaroli F (1980) Evaluation \u00e0 long terme de l'activit\u00e8 hypolipid\u00e8miante et de la tolerance du f\u00e9nofibrate. Nouv. Presse Med 9: 3747?3751","journal-title":"Nouv. Presse Med"},{"key":"CR2","first-page":"907","volume":"34","author":"D Sommariva","year":"1983","unstructured":"Sommariva D, Bonfiglioli D, Pogliaghi I, Zanaboni L, Balboni E, Paolino C, Fasoli A (1983) Effects of procetofen on serum lipids and lipoproteins and on plasma post-heparin lipase activities in type II and in type IV hyperlipoproteinemic patients. Curr Ther Res 34: 907?915","journal-title":"Curr Ther Res"},{"key":"CR3","first-page":"19","volume-title":"Drugs, lipid metabolism and atherosclerosis","author":"E Wulfert","year":"1978","unstructured":"Wulfert E (1978) Activity of 3-hydroxy-3-methylglutaryl Coenzyme A reducatse from rat and guinea pig liver. Specific inhibition studies and affinity chromatography. In: Kritchewsky D, Paoletti R, Holmes WL (eds) Drugs, lipid metabolism and atherosclerosis. Plenum Press, New York, p 19"},{"key":"CR4","first-page":"3733","volume":"9","author":"E Wulfert","year":"1980","unstructured":"Wulfert E (1980) Le f\u00e9nofibrate: par quel m\u00e9canisme produitil son effet hypocholest\u00e9rol\u00e9miante? Nouv Presse Med 9: 3733?3736","journal-title":"Nouv Presse Med"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0031-6989(82)80051-9","volume":"14","author":"C Massaroli","year":"1982","unstructured":"Massaroli C, Sommariva D, Bortolini U, Paolino C, Fasoli A (1982) Inactivation of 3-hydroxy-3-methylglutaryl Coenzyme A reductase in cultured human blood mononuclear cells by procetofenic acid. Pharmacol Res Commun 14: 51?60","journal-title":"Pharmacol Res Commun"},{"key":"CR6","first-page":"588","volume-title":"Mean and ideal body weight of adults","author":"Documenta Geigy Scientific Tables","year":"1960","unstructured":"Documenta Geigy Scientific Tables (1960) Mean and ideal body weight of adults, 6th edn. Geigy, Basel, p 588","edition":"6th edn."},{"key":"CR7","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0021-9150(78)90092-8","volume":"29","author":"D Sommariva","year":"1978","unstructured":"Sommariva D, Scotti L, Fasoli A (1978) Low-fat diet versus low-carbohydrate diet in the treatment of type IV hyperlipoproteinemia. Atherosclerosis 29: 43?51","journal-title":"Atherosclerosis"},{"key":"CR8","first-page":"891","volume":"43","author":"JL Beaumont","year":"1970","unstructured":"Beaumont JL, Carlson LA, Cooper GR, Fejfar Z, Fredrickson DS, Strasser T (1970) WHO classification of hyperlipidaemias and hyperlipoproteinaemias. WHO Bull 43: 891?915","journal-title":"WHO Bull"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/clinchem\/20.4.470","volume":"20","author":"CC Allain","year":"1974","unstructured":"Allain CC, Poon L, Chan CSG, Richmond W, Fu PC (1974) Enzymatic determination of total serum cholesterol. Clin Chem 20: 470?475","journal-title":"Clin Chem"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1093\/clinchem\/28.10.2077","volume":"28","author":"P Fossati","year":"1982","unstructured":"Fossati P, Principe L (1982) Serum triglycerides determined colorimetrically with an enzyme that produces H2O2. Clin Chem 28: 2077?2080","journal-title":"Clin Chem"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0025-7125(16)31433-X","volume":"66","author":"SM Groundy","year":"1982","unstructured":"Groundy SM (1982) Hypertriglyceridemia: mechanism, clinical, significance and treatment. Med Clin North Am 66: 519?535","journal-title":"Med Clin North Am"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/S0026-0495(64)80043-3","volume":"13","author":"D Steinberg","year":"1964","unstructured":"Steinberg D (1964) The fate of plasma free fatty acids and their effects on tissue metabolism. Metabolism 13: 1264?1272","journal-title":"Metabolism"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1126\/science.6261329","volume":"212","author":"MS Brown","year":"1981","unstructured":"Brown MS, Kovanen PT, Goldstein JL (1981) Regulation of plasma cholesterol by lipoprotein receptors. Science 212: 628?635","journal-title":"Science"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"4519","DOI":"10.1073\/pnas.75.9.4519","volume":"75","author":"JR Patsch","year":"1978","unstructured":"Patsch JR, Gotto AM Jr, Olivecrona T, Eisenberg S (1978) Formation of high-density lipoprotein2 like particles during lipolysis of very low density lipoproteins in vitro. Proc Nat Acad Sci 75: 4519?4523","journal-title":"Proc Nat Acad Sci"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/0002-9343(61)90220-0","volume":"31","author":"MJ Albrink","year":"1961","unstructured":"Albrink MJ, Meigs JW, Man EB (1961) Serum lipids, hypertension and coronary artery disease. Am J Med 31: 4?23","journal-title":"Am J Med"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0140-6736(72)90738-6","volume":"I","author":"LA Carlson","year":"1972","unstructured":"Carlson LA, B\u00f6ttiger LE (1972) Ischaemic heart disease in relation to fasting values of plasma triglycerides and cholesterol: Stockolm prospective study. Lancet I: 865?868","journal-title":"Lancet"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1161\/01.CIR.56.5.875","volume":"56","author":"AM Gotto Jr","year":"1977","unstructured":"Gotto AMJr, Gorry GA, Thompson JR, Cole JS, Trost R, Yeshurum D, De Bakely ME (1977) Relationship between plasma lipid concentrations and coronary artery disease in 496 patients. Circulation 56: 875?883","journal-title":"Circulation"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJM198006193022503","volume":"302","author":"SB Hulley","year":"1980","unstructured":"Hulley SB, Rosenman RH, Bawol RD, Brand RJ (1980) Epidemiology as a guide to clinical decisions: the association between triglyceride and coronary heart disease. N Engl J Med 302: 1383?1389","journal-title":"N Engl J Med"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/S0025-7125(16)32575-5","volume":"54","author":"EH Strisower","year":"1970","unstructured":"Strisower EH, Adamson G, Strisower B (1970) Treatment of hyperlipidemic states. Med Clin North Am 54: 1599?1613","journal-title":"Med Clin North Am"},{"key":"CR20","first-page":"170","volume-title":"Lipoprotein metabolism and therapy of lipid disorders","author":"P Weisweiler","year":"1982","unstructured":"Weisweiler P, Schwandt P (1982) Effect of bezafibrate on apolipoproteins in type IV hyperlipoproteinemia cases. In: Crepaldi G, Greten H, Schettler G, Baggio G (eds) Lipoprotein metabolism and therapy of lipid disorders. Excerpta Medica, Amsterdam Oxford Princeton, pp 170?172"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0021-9150(81)90134-9","volume":"40","author":"G Franceschini","year":"1981","unstructured":"Franceschini G, Poli A, Catapano AL, Gatti E, Sirtori M, Gianfranceschi G, Sirtori C (1981) Pharmacological studies on tiadenol in type IV patients. Evidence for a mechanism of action different from other lipid-lowering drugs. Atherosclerosis 40: 245?255","journal-title":"Atherosclerosis"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0140-6736(75)92376-4","volume":"I","author":"GJ Miller","year":"1975","unstructured":"Miller GJ, Miller NE (1975) Plasma high-density lipoprotein concentration and development of ischaemic heart disease. Lancet I: 16?19","journal-title":"Lancet"},{"issue":"Suppl II","key":"CR23","first-page":"74","volume":"60","author":"FU Beil","year":"1979","unstructured":"Beil FU, Crouse JR, Zech L, Grundy SM, Berman M (1979) Synthesis of cholesterol, bile acids and very low density lipoprotein-triglyceride in familial combined hyperlipidemia. Circulation (Suppl II) 60: 74","journal-title":"Circulation"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1365-2362.1980.tb02076.x","volume":"10","author":"ED Janus","year":"1980","unstructured":"Janus ED, Nicoll AM, Turner PR, Magill P, Lewis B (1980) Kinetic bases of the primary hyperlipoproteinemias. Studies of apolipoprotein B turnover in genetically defined subjects. Eur J Clin Invest 10: 161?172","journal-title":"Eur J Clin Invest"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/S0021-9258(18)96879-1","volume":"241","author":"MD Siperstein","year":"1966","unstructured":"Siperstein MD, Fagan VD (1966) Feed-back control of mevalonate synthesis by dietary cholesterol. J Biol Chem 241: 602?609","journal-title":"J Biol Chem"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1056\/NEJM198108273050909","volume":"305","author":"MS Brown","year":"1981","unstructured":"Brown MS, Goldstein JL (1981) Lowering plasma cholesterol by raising LDL receptors. N Engl J Med 305: 515?517","journal-title":"N Engl J Med"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.0954-6820.1979.tb13526.x","volume":"206","author":"LH Carlson","year":"1979","unstructured":"Carlson LH, Bottiger LE, Ahfeldt PE (1979) Risk factors for myocardial infarction in the Stockholm prospective study: A 14 year follow-up focusing on the role of plasma triglycerides and cholesterol. Acta Med Scand 206: 351?360","journal-title":"Acta Med Scand"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00541935.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00541935\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00541935","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T02:25:56Z","timestamp":1624933556000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00541935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1984]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1984]]}},"alternative-id":["BF00541935"],"URL":"https:\/\/doi.org\/10.1007\/bf00541935","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[1984]]}}}